Evidence map›Paper›PMID 42346961›Full record

ReviewMembranes2026

A Green Approach Towards Desalination: Sustainable Poly(lactic acid) Membranes for Pervaporation Desalination.

Urooj Ahmad, Bart Van der Bruggen, Xing Yang

Abstract readReview
In one paragraph

Review in Membranes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Urooj AhmadDepartment of Chemical Engineering, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
Bart Van der BruggenDepartment of Chemical Engineering, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.
Xing YangDepartment of Chemical Engineering, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium.ORCID 0000-0002-8403-8254

Funding

KU Leuven KU Leuven C16/23/006
6 · The paper itself

Abstract

To address the global water crisis, desalination technologies contribute about 1% of the global freshwater supply. Membrane-based desalination technologies offer high performance, operational ease, cost-effectiveness and high scalability compared to conventional thermal desalination modes. Among all membrane-based technologies, reverse osmosis is prevailing globally. However, the high energy demand of the reverse osmosis process and fouling in case of hypersaline feed streams motivate the exploration of alternative technologies, i.e., pervaporation. Pervaporation desalination involves dense hydrophilic polymer membranes to deal with high salt streams at low cost, along with less fouling than a few other membrane processes, i.e., reverse osmosis and membrane distillation. Mass transport through pervaporation desalination membranes is well-explained by solution-diffusion theory involving a tri-stage transfer, i.e., sorption, diffusion and evaporation. Since the last few decades, a green approach in all domains has offered chemical products and processes with the least hazards and minimal waste production. Application of biodegradable materials like poly(lactic acid) in combination with suitable green solvents, e.g., ethyl lactate, methyl lactate, cyrene, dimethyl isosorbide and gamma valerolactone for pervaporation desalination would be a good roadmap to meet the sustainability criterion. Some intrinsic features of poly(lactic acid) that make it a 'material of choice' for pervaporation desalination include hydrophilicity imparted by the presence of polar ester groups, high salt rejection, biodegradability with simple mineralization products, i.e., H

Indexed as

desalinationgreen chemistrymembranespervaporationpoly(lactic acid)

Identifiers

PMID42346961
PMCPMC13303272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.